CDKN2B anticorps
CDKN2B
Reactivité: Humain
WB, IHC, FACS, IF/ICC
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN2996859
-
-
Antigène
Voir toutes CDKN2B Anticorps
-
CDKN2B
(Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp CDKN2B est non-conjugé
-
Application
-
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunofluorescence (fixed cells) (IF/ICC)
-
Purification
-
This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
-
Human CDKN2B.
-
Isotype
-
IgG
-
Top Product
-
Discover our top product CDKN2B Anticorps primaire
-
-
-
Indications d'application
-
Optimal working dilution should be determined by the investigator.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C
-
Stockage commentaire
-
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
Antigène
-
CDKN2B
(Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Autre désignation
-
CDKN2B (CDKN2B Produits)
-
Synonymes
-
anticorps p14-INK4b, anticorps cdk4l, anticorps ink4b, anticorps mts2, anticorps p15, anticorps p15ink4b, anticorps tp15, anticorps CDK4I, anticorps INK4B, anticorps MTS2, anticorps P15, anticorps TP15, anticorps p15INK4b, anticorps AV083695, anticorps INK4b, anticorps p15(INK4b), anticorps CDKN2A, anticorps cyclin dependent kinase inhibitor 2B, anticorps Cyclin-dependent kinase 4 inhibitor B, anticorps cyclin-dependent kinase inhibitor 2B, anticorps cyclin-dependent kinase inhibitor 2B L homeolog, anticorps cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), anticorps CDKN2B, anticorps cdn2b, anticorps cdkn2b, anticorps cdkn2b.L, anticorps Cdkn2b
-
UniProt
-
P42772
-
Pathways
-
Cycle Cellulaire, Mitotic G1-G1/S Phases
-